Did not become law. It stopped in the House of Representatives's Health Committee on May 5, 2023. The 2023–2024 session has ended.
2023–2024 Regular Session
House Bill 1123
An Act providing for prescribing and dispensing drugs approved by the United States Food and Drug Administration for off-label use to treat coronavirus infections causing respiratory-syndrome-related illnesses.
Sponsors
Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.
In the House of Representatives
Sponsor
7 co-sponsors
Joe Hamm, ROB W. KAUFFMAN, Joseph D'Orsie, David H. Rowe, David H. Zimmerman, Barbara Gleim, Robert Leadbeter
Its course
May 5 to May 5, 2023, on one scale. In the top row each mark is a day something happened; taller marks are busier days.
Each committee stop sits inside its chamber.
Every action1 action on 1 day
In the House of RepresentativesMay 5 to May 5 · stopped0 days
HealthMay 5 to May 5 · stopped0 days
Text
Each version as the General Assembly printed it.
l9n doesn't hold this bill's text yet.
What happened
In l9n's words, one line for each step. Every action as the General Assembly published it is below.